Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning pathophysiological mechanisms are still incompletely understood. This may be due to the use of different animal models and resulting model-associated variation. Therefore, this study aimed to compare three frequently used wild type mouse strains in their susceptibility to develop diet-induced features of non-alcoholic/alcoholic fatty liver disease. Fatty liver disease associated clinical, biochemical, and histological features in C57BL/6, CD-1, and 129Sv WT mice were induced by (i) high-fat diet feeding, (ii) ethanol feeding only, and (iii) the combination of high-fat diet and ethanol feeding. Hepatic and subcutaneous adipose lipid profiles we...
non-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed worl...
Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) are increasing prob...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning p...
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are usuall...
Background: The prevalence of metabolic liver diseases is increasing and approved pharmacological tr...
Background: The prevalence of metabolic liver diseases is increasing and approved pharmacological tr...
Alcoholic liver disease (ALD) is an important worldwide public health issue characterized by liver s...
A rapidly increasing incidence of non-alcoholic fatty liver disease (NAFLD) is noted worldwide due t...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
Abstract Background Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are p...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
AbstractThe major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin re...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
non-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed worl...
Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) are increasing prob...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...
Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning p...
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are usuall...
Background: The prevalence of metabolic liver diseases is increasing and approved pharmacological tr...
Background: The prevalence of metabolic liver diseases is increasing and approved pharmacological tr...
Alcoholic liver disease (ALD) is an important worldwide public health issue characterized by liver s...
A rapidly increasing incidence of non-alcoholic fatty liver disease (NAFLD) is noted worldwide due t...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
Abstract Background Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are p...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
AbstractThe major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin re...
Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver d...
non-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed worl...
Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) are increasing prob...
<div><p>Background and aims</p><p>Non-alcoholic steatohepatitis (NASH), the potentially progressive ...